Developer docs
API playgroundTry for free, no card

Search company profiles

IOP Ophthalmics

Full company profile

uuid0022kfu

Namestring
IOP Ophthalmics
Websiteurl
iopinc.com
Company typeenum
Private
Founded yearint
1988
Short descriptiontext

IOP Ophthalmics is a privately held medical device company that develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics to ophthalmic surgeons and surgical centers. Founded 1988 in Costa Mesa, California, it operates with 1-10 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCosta Mesa, United States
HQ citystring
Costa Mesa
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
ophthalmic surgical devices, ocular biologics, eye surgery products, specialty ophthalmics, ophthalmic instruments
Industry3 codes
1Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
CodeHLAHAJAHPrimaryYes
2Ophthalmology Pharmaceuticals
CodeHLAIAAALPrimaryNo
3Ocular Drug Delivery Devices (Eye Droppers/Inserts)
CodeHLAHAIALPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Ophthalmic Goods Merchant Wholesalers423460
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Surgical Devices
Social media profiles1 record
Cost components4 values
Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

IOP Ophthalmics develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics used in eye surgery procedures. The company focuses on bringing niche ophthalmic surgical products to market, serving eye surgeons and ophthalmic surgical practices.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Specialty Ophthalmic Surgical Devices
CategoryOphthalmic Surgical Devices
Description

Developed and commercialized surgical devices designed for use in ophthalmic surgical procedures, targeted at ophthalmic surgeons and surgical practices.

2Ophthalmic Biologics
CategoryOphthalmic Biologics
Description

Biological products for ophthalmic surgical use, distributed to ophthalmologists and eye surgery centers.

No data
Peers10 records
TypeBroad incumbent
Description

The largest dedicated ophthalmic surgical and vision care company worldwide, competing directly across cataract surgical devices, IOLs, and ocular pharmaceuticals/biologics where IOP Ophthalmics operates. A relevant scale benchmark for IOP's surgical device and biologic offerings.

TypeDirect peer
Description

Commercial-stage ophthalmic surgical device company developing minimally invasive glaucoma and dry-eye surgical devices. Comparable in size, specialty focus, and surgeon-direct distribution model to IOP Ophthalmics.

TypeDirect peer
Description

Specialty ophthalmic company developing sustained-release biologic and small-molecule drug delivery platforms (DURYSTA, ongoing pipeline). Comparable to IOP's biologics and ocular drug-delivery positioning.

TypeDirect peer
Description

Privately held, specialty manufacturer and distributor of ophthalmic surgical instruments, IOLs, and adjunctive surgical products. Closely mirrors IOP's combined develop-and-distribute specialty ophthalmic surgical device business.

TypeDirect peer
Description

A specialty ophthalmic surgical device company focused on interventional glaucoma and drug-delivery platforms (MIGS, iDose). Comparable to IOP as a smaller-cap, niche ophthalmic device-plus-biologic developer commercializing through a dedicated sales force.

TypeBroad incumbent
Description

Provides ophthalmic surgical devices, intraoperative diagnostics, and IOLs used in cataract and refractive surgery. Directly comparable to IOP's surgical device scope and serves the same OR/ASC customer base.

TypeDirect peer
Description

Biopharmaceutical company developing ophthalmic biologics and drug-delivery technologies (e.g., DEXTENZA, OTX-TKI). Closely comparable to IOP's biologics arm and aligns with IOP's combination of ophthalmic devices and biologic drug delivery.

TypeDirect peer
Description

Specialty ophthalmic surgical instrument and disposable manufacturer serving cataract and vitreoretinal surgeons. A close comparator to IOP as a privately held, niche-focused surgical ophthalmic device company.

TypeDirect peer
Description

Manufactures and distributes specialty ophthalmic surgical instruments and consumables used by cataract and glaucoma surgeons. Comparable to IOP's surgical device manufacturing and distribution model.

TypeBroad incumbent
Description

Operates a broad ophthalmic surgical portfolio (including its BVI Medical carve-out) covering cataract, vitreoretinal, and dry-eye/ocular surface products. Comparable to IOP in that it sells specialty ophthalmic surgical devices alongside biologic-adjacent ocular surface therapeutics.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IOP Ophthalmics

Ophthalmic Surgical Devicesiopinc.com

IOP Ophthalmics is a privately held medical device company that develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics to ophthalmic surgeons and surgical centers. Founded 1988 in Costa Mesa, California, it operates with 1-10 employees.

IOP Ophthalmics firmographics

Firmographics
Name
IOP Ophthalmics
Website
https://iopinc.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
1–10 employees
Short description
IOP Ophthalmics is a privately held medical device company that develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics to ophthalmic surgeons and surgical centers. Founded 1988 in Costa Mesa, California, it operates with 1-10 employees.
Ownership category
akta.pro rank

IOP Ophthalmics industry classification

Industry
Product category
Ophthalmic Surgical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Merchant Wholesalers (423460)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
akta.pro secondary industries
Ophthalmology Pharmaceuticals (HLAIAAAL), Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

Keywords

  • Ophthalmic surgical devices
  • Ocular biologics
  • Eye surgery products
  • Specialty ophthalmics
  • Ophthalmic instruments

Where IOP Ophthalmics is headquartered

Location

Headquarters

HQ city
Costa Mesa
HQ country
United States
HQ region
North America

Markets served

IOP Ophthalmics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales

IOP Ophthalmics product offering

Product offering

Core offering

IOP Ophthalmics develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics used in eye surgery procedures. The company focuses on bringing niche ophthalmic surgical products to market, serving eye surgeons and ophthalmic surgical practices.

Differentiator

Problem solved

Functional benefit

Products and services

  • Specialty Ophthalmic Surgical Devices Developed and commercialized surgical devices designed for use in ophthalmic surgical procedures, targeted at ophthalmic surgeons and surgical practices.
  • Ophthalmic Biologics Biological products for ophthalmic surgical use, distributed to ophthalmologists and eye surgery centers.

Companies that use IOP Ophthalmics

Customer profile

Ideal customer profiles1 record

IOP Ophthalmics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

IOP Ophthalmics competitors and assessment

Company assessment

Broad incumbents

  • Alcon: The largest dedicated ophthalmic surgical and vision care company worldwide, competing directly across cataract surgical devices, IOLs, and ocular pharmaceuticals/biologics where IOP Ophthalmics operates. A relevant scale benchmark for IOP's surgical device and biologic offerings.
  • Carl Zeiss Meditec: Provides ophthalmic surgical devices, intraoperative diagnostics, and IOLs used in cataract and refractive surgery. Directly comparable to IOP's surgical device scope and serves the same OR/ASC customer base.
  • Bausch + Lomb (BVI Medical): Operates a broad ophthalmic surgical portfolio (including its BVI Medical carve-out) covering cataract, vitreoretinal, and dry-eye/ocular surface products. Comparable to IOP in that it sells specialty ophthalmic surgical devices alongside biologic-adjacent ocular surface therapeutics.

Direct peers

  • SightSciences: Commercial-stage ophthalmic surgical device company developing minimally invasive glaucoma and dry-eye surgical devices. Comparable in size, specialty focus, and surgeon-direct distribution model to IOP Ophthalmics.
  • EyePoint Pharmaceuticals: Specialty ophthalmic company developing sustained-release biologic and small-molecule drug delivery platforms (DURYSTA, ongoing pipeline). Comparable to IOP's biologics and ocular drug-delivery positioning.
  • Katena Products: Privately held, specialty manufacturer and distributor of ophthalmic surgical instruments, IOLs, and adjunctive surgical products. Closely mirrors IOP's combined develop-and-distribute specialty ophthalmic surgical device business.
  • Glaukos Corporation: A specialty ophthalmic surgical device company focused on interventional glaucoma and drug-delivery platforms (MIGS, iDose). Comparable to IOP as a smaller-cap, niche ophthalmic device-plus-biologic developer commercializing through a dedicated sales force.
  • Ocular Therapeutix: Biopharmaceutical company developing ophthalmic biologics and drug-delivery technologies (e.g., DEXTENZA, OTX-TKI). Closely comparable to IOP's biologics arm and aligns with IOP's combination of ophthalmic devices and biologic drug delivery.
  • Microsurgical Technology: Specialty ophthalmic surgical instrument and disposable manufacturer serving cataract and vitreoretinal surgeons. A close comparator to IOP as a privately held, niche-focused surgical ophthalmic device company.
  • Rhein Medical (a division of Inami): Manufactures and distributes specialty ophthalmic surgical instruments and consumables used by cataract and glaucoma surgeons. Comparable to IOP's surgical device manufacturing and distribution model.

Market position

Customer concentration

IOP Ophthalmics social profiles

Digital presence

IOP Ophthalmics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IOP Ophthalmics leadership team

Management profile

Number of profiles

IOP Ophthalmics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IOP Ophthalmics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IOP Ophthalmics

What does IOP Ophthalmics do?

IOP Ophthalmics develops, commercializes, and distributes specialty ophthalmic surgical devices and biologics used in eye surgery procedures. The company focuses on bringing niche ophthalmic surgical products to market, serving eye surgeons and ophthalmic surgical practices.

Is IOP Ophthalmics a public or private company?

IOP Ophthalmics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was IOP Ophthalmics founded?

IOP Ophthalmics was founded in 1988. It employs 1 to 10 people.

Where is IOP Ophthalmics based?

IOP Ophthalmics is headquartered in Costa Mesa, United States, in the North America region.

Who are IOP Ophthalmics's main competitors?

Broad incumbents on record are Alcon, Carl Zeiss Meditec and Bausch + Lomb (BVI Medical). Direct peers are SightSciences, EyePoint Pharmaceuticals, Katena Products, Glaukos Corporation, Ocular Therapeutix, Microsurgical Technology and Rhein Medical (a division of Inami).

Does IOP Ophthalmics have an API?

No public API is recorded for IOP Ophthalmics.

What industry is IOP Ophthalmics in?

IOP Ophthalmics's product category is Ophthalmic Surgical Devices. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics), with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals